NCT06857695View on ClinicalTrials.gov

A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

March 6, 2025

Primary Completion Date

May 5, 2025

Study Completion Date

May 5, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD5004 film-coated tablet

oral, fasted

DRUG

[14C]AZD5004 Solution for Infusion

intravenous, fasted

DRUG

[14C]AZD5004 Oral Solution

oral, fasted

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY